3.08
0.33%
0.01
Curis Inc Aktie (CRIS) Neueste Nachrichten
Curis Inc (CRIS) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 - The Eastern Progress Online
Curis stock plunges to 52-week low, hits $3.5 amid downturn By Investing.com - Investing.com South Africa
Curis stock plunges to 52-week low, hits $3.5 amid downturn - Investing.com Canada
Curis reports promising AML study results By Investing.com - Investing.com Canada
Curis, Inc. Announces Additional Data from Take Aim Leukemia Study - Marketscreener.com
Curis reports promising AML study results - Investing.com India
Curis Announces Additional Data from TakeAim Leukemia Study - PR Newswire
Curis (NASDAQ:CRIS) Shares Down 2.3% – Time to Sell? - Defense World
Curis (CRIS) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
Curis to Present at Upcoming Healthcare Conferences in September - The Eastern Progress Online
Curis Inc (CRIS) Stock Surges 5.46% Amid Positive Analyst Ratings - GuruFocus.com
Curis Announces $12.1 Million Registered Direct and Concurrent P - GuruFocus.com
Curis to Report Third Quarter 2024 Financial and Operating Resul - GuruFocus.com
Curis Provides Third Quarter 2024 Business Update - GuruFocus.com
Curis: Q3 Earnings Snapshot - Marketscreener.com
Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Curis’ (CRIS) Buy Rating Reiterated at HC Wainwright - Defense World
Curis Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Curis, Inc. (NASDAQ:CRIS) Q3 2024 Earnings Call Transcript - Insider Monkey
Curis Inc (CRIS) Q3 2024 Earnings Call Highlights: Navigating Fi - GuruFocus.com
Curis Inc (CRIS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ... - Yahoo Finance
Earnings call: Curis Reports Progress in Clinical Studies and Financials - Investing.com India
Curis Inc. Reports Positive Q3 2024 Earnings - TipRanks
Curis reports progress in clinical trials By Investing.com - Investing.com Australia
Curis Inc (CRIS) Quarterly 10-Q Report - Quartzy
Curis Inc (CRIS) Q3 2024 Earnings: Revenue Surpasses Estimates a - GuruFocus.com
Curis reports progress in clinical trials - Investing.com
Curis Reports Improved Q3 Loss, Achieves Strong Clinical Response in Cancer Study | CRIS Stock News - StockTitan
Curis, Inc.'s (NASDAQ:CRIS) 26% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St
Curis (FRA:CUS0) Total Inventories : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
Kingdon Capital Management Reduces Stake in Curis Inc - GuruFocus.com
Curis stock touches 52-week low at $3.95 amid market challenges - Investing.com India
Curis Inc (CRIS) Q3 2024: Everything You Need to Know Ahead of E - GuruFocus.com
Curis (CRIS) Set to Announce Quarterly Earnings on Thursday - Defense World
Curis (CRIS) to Report Q3 2024 Earnings: Key Updates on IRAK4 Inhibitor Progress | CRIS Stock News - StockTitan
Curis Inc. (CRIS) Stock Surges 5.08% Amid Strong Biotech Sector Performance - GuruFocus.com
Curis stock hits 52-week low at $4.05 amid market challenges - Investing.com Canada
Curis shares remain Buy-rated, H.C. Wainwright lowers target after cash infusion extends runway - Investing.com Canada
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):